The effect of the physical activity on polymorphic premature ventricular complexes in chronic kidney disease

by Márcio G. Kiuchi, Shaojie Chen
Published 2017-06-01

Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?

by Márcio G. Kiuchi, Decio Mion Jr.
Published 2016-03-01

The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-α

by Aaron L. Magno, Lakshini Y. Herat, Márcio G. Kiuchi, Markus P. Schlaich, Natalie C. Ward, Vance B. Matthews
Published 2020-08-01

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation

by Revathy Carnagarin, Marcio G. Kiuchi, Jan K. Ho, Vance B. Matthews, Markus P. Schlaich, Markus P. Schlaich, Markus P. Schlaich
Published 2019-01-01

The Schlager mouse as a model of altered retinal phenotype

by Lakshini Y Herat, Aaron L Magno, Márcio G Kiuchi, Kristy L Jackson, Revathy Carnagarin, Geoffrey A Head, Markus P Schlaich, Vance B Matthews
Published 2020-01-01

Pulmonary vein isolation alone and combined with renal sympathetic denervation in chronic kidney disease patients with refractory atrial fibrillation

by Márcio G. Kiuchi, Shaojie Chen, Gustavo R. e Silva, Luis M.R. Paz, Tetsuaki Kiuchi, Ary G. de Paula Filho, Gladyston L.L. Souto
Published 2016-12-01

Detection of autonomic dysfunction in hemodialysis patients using the exercise treadmill test: the role of the chronotropic index, heart rate recovery, and R-R variability.

by Maria Angela M Q Carreira, André B Nogueira, Felipe M Pena, Marcio G Kiuchi, Ronaldo C Rodrigues, Rodrigo R Rodrigues, Jorge P S Matos, Jocemir R Lugon
Published 2015-01-01

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation

by Revathy Carnagarin, Kearney Tan, Leon Adams, Vance B. Matthews, Marcio G. Kiuchi, Leslie Marisol Lugo Gavidia, Gavin W. Lambert, Elisabeth A. Lambert, Lakshini Y. Herat, Markus P. Schlaich
Published 2021-04-01

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)

by Jia Liao, Ramin Ebrahimi, Zhiyu Ling, Christian Meyer, Martin Martinek, Philipp Sommer, Piotr Futyma, Davide Di Vece, Alexandra Schratter, Willem-Jan Acou, Lin Zhu, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Helmut Pürerfellner, Christian Templin, Shaojie Chen
Published 2024-02-01

SGLT2 Inhibitor–Induced Sympathoinhibition

by Lakshini Y. Herat, PhD, Aaron L. Magno, PhD, Caroline Rudnicka, BSc (Hons), Jana Hricova, BSc, MSc, Revathy Carnagarin, MBBS, MS, MD, PhD, Natalie C. Ward, PhD, Angelique Arcambal, PhD, Marcio G. Kiuchi, MD, MSc, PhD, Geoff A. Head, PhD, Markus P. Schlaich, MD, Vance B. Matthews, PhD
Published 2020-02-01